Source: ESPN Author: Ric Bucher Denver Nuggets coach George Karl informed his team Tuesday afternoon that he is in another fight for his life with cancer. Karl, who had been cancer-free since prostate surgery in July 2005, discovered a worrisome lump on his neck about six weeks ago. A biopsy determined that it was “very treatable and curable” [...]
Continue reading...Thursday, February 11, 2010
Source: CancerConsultants Author: Staff Researchers from Italy have reported that induction (neoadjuvant) chemotherapy prior to concomitant chemoradiotherapy improves outcomes of patients with locally advanced head and neck cancer. The details of this Phase II randomized trial were published early online in the Annals of Oncology on December 23, 2009.[1] There have been several randomized and non-randomized clinical trials suggesting [...]
Continue reading...Saturday, December 19, 2009
Source: www.healthcanal.com Author: staff A minimally invasive surgical approach developed by head and neck surgeons at the University of Pennsylvania School of Medicine has been cleared by the U.S. Food and Drug Administration (FDA). The da Vinci Surgical System (Intuitive Surgical, Inc., Sunnyvale, California) has been cleared for TransOral Otolaryngology surgical procedures to treat benign tumors and [...]
Continue reading...Wednesday, December 2, 2009
Source: www2.mdanderson.org/cancerwise Author: Cancerwise Blogger In certain cases, cancer of the larynx (voicebox) can be treated successfully with chemotherapy alone, according to a recent study at M. D. Anderson. Chris Holsinger, M.D., assistant professor in the Department of Head and Neck Surgery, was co-author of the study, which is the first of its kind in the United States. [...]
Continue reading...Tuesday, November 17, 2009
Source: Arch Otolaryngol Head Neck Surg. 2009;135(11):1133-1136 Author: Alexander Langerman, MD et al. Complete Radiographic Response Correlates With Pathologic Complete Response in Locoregionally Advanced Head and Neck Cancer Objective: The role of neck dissection following chemoradiotherapy (CRT) for locoregionally advanced head and neck cancer is an area of active debate. Patients who have a complete radiographic response may [...]
Continue reading...Monday, November 16, 2009
Source: www.vwd.de Author: press release The American Society of Clinical Oncology (ASCO) has once again recognized Erbitux® (cetuximab) as one of the major clinical cancer advances of 2009. This year Erbitux was selected by ASCO for providing the first significant increase in survival for 30 years in the treatment of patients with first-line recurrent and/or metastatic squamous [...]
Continue reading...Wednesday, November 11, 2009
Source: www.privatemdlabs.com Author: Brendan Missett Patients with head and neck cancer receiving a combined treatment of chemotherapy and radiation may live 2.1 years longer than those treated only with radiotherapy, new research suggests. The study, published in the October 27 issue of The Lancet Oncology, separated 966 patients with advanced head and neck cancer into four treatment [...]
Continue reading...Wednesday, November 11, 2009
Source: www.docguide.com Author: John Otrompke Patients with head and neck squamous cell carcinoma who receive an average weekly fractionated radiation dose of more than 10 gy experience significantly better local control at 2 years, unless they are receiving chemotherapy at the same time, according to a study presented here at the American Society of Therapeutic Radiology and [...]
Continue reading...Thursday, November 5, 2009
Source: www.medscape.com Author: Zosia Chustecka In patients with head and neck cancer who do not undergo surgery, chemotherapy with nonplatinum agents given concurrently with radiotherapy offers clear benefits for recurrence and survival, say the authors of one of the largest and longest randomized trials carried out in this patient group. Event-free survival in patients who received concomitant chemoradiation [...]
Continue reading...Wednesday, November 4, 2009
Source: www.sciencecodex.com Author: staff Clinical researchers at Princess Margaret Hospital (PMH) have confirmed that patients with oropharyngeal squamous cell cancer (”tonsil cancer”) harbour a common type of human papilloma virus (HPV16), but also that such cancers are very sensitive to radiation. For some patients, this may mean successful treatment with radiation alone and avoiding the side effects [...]
Continue reading...
Wednesday, February 17, 2010
0 Comments